These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37736631)

  • 1. Toward a molecular mechanism for the interaction of ATP with alpha-synuclein.
    Kamski-Hennekam ER; Huang J; Ahmed R; Melacini G
    Chem Sci; 2023 Sep; 14(36):9933-9942. PubMed ID: 37736631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of α-Synuclein: Implications for Parkinson's Disease.
    Meena VK; Kumar V; Karalia S; Garima ; Sundd M
    ACS Chem Neurosci; 2021 Oct; 12(19):3598-3614. PubMed ID: 34506119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.
    Yang X; Wang B; Hoop CL; Williams JK; Baum J
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.
    Wood A; Chau E; Yang Y; Kim JR
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1411-1424. PubMed ID: 31776941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative.
    Chau E; Kim H; Shin J; Martinez A; Kim JR
    Biochem Biophys Res Commun; 2021 Oct; 574():85-90. PubMed ID: 34454326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.
    Rajsombath MM; Nam AY; Ericsson M; Nuber S
    J Neurosci; 2019 Sep; 39(38):7628-7640. PubMed ID: 31405930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.
    Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets.
    Iyer A; Roeters SJ; Kogan V; Woutersen S; Claessens MMAE; Subramaniam V
    J Am Chem Soc; 2017 Nov; 139(43):15392-15400. PubMed ID: 28968082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical nucleus of Greek-key-like core of α-synuclein protofibril and its disruption by dopamine and norepinephrine.
    Zou Y; Qian Z; Gong Y; Tang Y; Wei G; Zhang Q
    Phys Chem Chem Phys; 2019 Dec; 22(1):203-211. PubMed ID: 31799519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein.
    Mohammadi S; Nikkhah M
    Iran J Biotechnol; 2017; 15(2):87-94. PubMed ID: 29845055
    [No Abstract]   [Full Text] [Related]  

  • 12. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Candreva J; Chau E; Rice ME; Kim JR
    Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the Self-assembly Dynamics of Imperfect Repeats in α-Synuclein.
    Huang F; Wang Y; Zhang Y; Wang C; Lian J; Ding F; Sun Y
    J Chem Inf Model; 2023 Jun; 63(11):3591-3600. PubMed ID: 37253119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane Interactions of α-Synuclein Revealed by Multiscale Molecular Dynamics Simulations, Markov State Models, and NMR.
    Amos STA; Schwarz TC; Shi J; Cossins BP; Baker TS; Taylor RJ; Konrat R; Sansom MSP
    J Phys Chem B; 2021 Mar; 125(11):2929-2941. PubMed ID: 33719460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
    Janowska MK; Wu KP; Baum J
    Sci Rep; 2015 Oct; 5():15164. PubMed ID: 26477939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
    Coskuner O; Wise-Scira O
    ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Library-Derived Peptide Aggregation Modulators of Parkinson's Disease Early-Onset α-Synuclein Variants.
    Watt KJC; Meade RM; Williams RJ; Mason JM
    ACS Chem Neurosci; 2022 Jun; 13(12):1790-1804. PubMed ID: 35613323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.
    Janowska MK; Baum J
    Protein Sci; 2016 Jan; 25(1):286-94. PubMed ID: 26332674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide.
    Mohammadi S; Nikkhah M; Hosseinkhani S
    Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.